A company insider recently sold 12,300 shares of Thermo Fisher Scientific Inc. [TMO]. Should You Sale?

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Thermo Fisher Scientific Inc. shares valued at $7,422,789 were sold by Williamson Stephen on Aug 15. At $603.48 per share, Williamson Stephen sold 12,300 shares. The insider’s holdings dropped to 43,944 shares worth approximately $22.86 million following the completion of this transaction.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored


Also, Williamson Stephen sold 15,000 shares, netting a total of over 9,019,813 in proceeds. Following the sale of shares at $601.32 each, the insider now holds 43,944 shares.

Before that, Boxer Michael A had sold 7,283 shares from its account. In a trade valued at $4,302,796, the SVP and General Counsel traded Thermo Fisher Scientific Inc. shares for $590.80 each. Upon closing the transaction, the insider’s holdings decreased to 7,283 shares, worth approximately $6.45 million.

As published in their initiating research note from Credit Suisse on August 25, 2022, Thermo Fisher Scientific Inc. [TMO] has been a Neutral and the price target has been revised to $675. This represents a 22.92% premium over Thursday’s closing price. Analysts at Wells Fargo downgraded the stock from ‘”an Equal weight”‘ to ‘”an Underweight”‘ outlook in a report released in late April. Earlier on October 20, 2021, Citigroup upgraded its rating. Their new recommendation was “a Buy” for TMO stock which previously was a “a Neutral”.

Analyzing TMO’s Price Performance

On Thursday, Thermo Fisher Scientific Inc. [NYSE: TMO] plunged -1.03% to $520.29. The stock’s lowest price that day was $518.57, but it reached a high of $526.96 in the same session. During the last five days, there has been a drop of approximately -5.74%. Over the course of the year, Thermo Fisher Scientific Inc. shares have dropped approximately -22.02%. Shares of the company reached a 52-week high of $664.27 on 01/03/22 and a 52-week low of $497.83 on 06/16/22. A 50-day SMA is recorded $567.24, while a 200-day SMA reached $570.88. Nevertheless, trading volume fell to 1.13 million shares from 1.27 million shares the previous day.

Support And Resistance Levels for Thermo Fisher Scientific Inc. (TMO)

According to the 24-hour chart, there is a support level at 516.92, which, if violated, would cause prices to drop to 513.55. In the upper region, resistance lies at 525.31. The next price resistance is at 530.33. RSI (Relative Strength Index) is 31.30 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -22.85, which suggests the price will decrease in the coming days. Percent R is at 97.21%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is Thermo Fisher Scientific Inc. subject to short interest?

Stocks of Thermo Fisher Scientific Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.15 million shares to 2.75 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 2.6 million shares. A jump of 5.45% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.2 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.2.

Which companies own the most shares of Thermo Fisher Scientific Inc. (TMO)?

According to The Vanguard Group, Inc. filings, the company currently owns 30,185,101 shares, which is about 7.70% of the total TMO shares outstanding. The investor’s shares have appreciated by 277,618 from its previous 13-F filing of 29907483.0 shares. With the completion of the sale transaction, BlackRock Fund Advisors’s stake is now worth $10,299,104,382. SSgA Funds Management, Inc. reduced a -1.20% interest valued at $8.74 billion while Capital Research & Management Co sold a -177,932 stake. A total of -1,784,259 shares of Thermo Fisher Scientific Inc. were sold by T. Rowe Price Associates, Inc. during the quarter, and -481,174 were sold by Massachusetts Financial Services. In its current portfolio, Fidelity Management & Research Co holds 8,848,550 shares valued at $4.83 billion.

In terms of Thermo Fisher Scientific Inc. share price expectations, FactSet research, analysts set an average price target of $660.15 in the next 12 months, up nearly 26.98% from the previous closing price of $525.69. Analysts anticipate Thermo Fisher Scientific Inc. stock to reach $715.00 by 2022, with the lowest price target being $525.00. In spite of this, 24 analysts ranked Thermo Fisher Scientific Inc. stock as an Overweight at the end of 2022. On October 15, 2021, Cowen assigned a price target of “an Outperform” to the stock and resumed coverage with a $696.

LEAVE A REPLY

Please enter your comment!
Please enter your name here